Morishima Yasuo | Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
スポンサーリンク
概要
関連著者
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
三木 義男
癌研ゲノムセンター
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
東海大学 医学部
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
谷脇 雅文
高知工科大学工学部
-
OHNO Ryuzo
Aichi Cancer Center
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Maruyama Dai
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
永井 正
自治医科大学内科学講座血液学部門
-
MIYAGI MAESHIMA
Clinical Laboratory, National Cancer Center Hospital
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
KATO Shunichi
Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine
-
Kato Harumi
Department of Cardiology, Kurashiki Central Hospital
-
NOMOTO Junko
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
KIM Sung-Won
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
Sasaki Nana
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
KATO Yukio
Department of Dental and Medical Biochemistry, Hiroshima University Graduate School of Biomedical Sc
-
ANDO Kiyoshi
Department of Hematology/Oncology, Tokai University School of Medicine
-
Kawabata S
Second Dep. Of Internal Medicine Nagasaki Univ. School Of Medicine
-
Takishita S
University Of The Ryukyus
-
SHIMADA Kazuyuki
Department of Medicine, Jichi Medical University
-
Mizuno Kyoichi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
-
Matsuda Koichi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Mizuno Kyoichi
日本医科大学 内科学
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
上平 憲
長崎大学臨床検査医学
-
Sugahara Kazuyuki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
TANIGUCHI Hirokazu
Clinical Laboratory, National Cancer Center Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
Ohashi Yasuo
Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences a
-
Kohno Shigeru
佐世保市立総合病院 内科
-
Doi Yuko
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Sakata Toshiie
山口大学 医学系研究科器官病態内科学
-
Tanaka Satoshi
Department Of Nutritional Sciences Faculty Of Nutritional Science Nakamura Gakuen University
-
Kawakami S
Department Of Laboratory Medicine Nagasaki University Graduate School Of Biomedical Sciences
-
Nakamura Yusuke
東京大学医科学研究所ヒトゲノム解析センター ゲノムシークエンス解析分野
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
TERAUCHI Takashi
Screening Technology and Development Division, Research Center for Cancer Prevention and Screening,
-
ASANO Naoko
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center
-
Nagane Y
Sanai Hospital Iwate Jpn
-
Nagane Yutaka
東京大学医科学研究所ヒトゲノム解析センター
-
Nagane Yutaka
Department Of Urology Sanai Hospital
-
Honda Sumihisa
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences
-
上平 憲
長崎大学医学部附属病院検査部
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
YABE Hiromasa
Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine
-
YABE Miharu
Department of Cell Transplantation and Laboratory Medicine, Tokai University School of Medicine
-
佐々木 毅
東北大学大学院医学系研究科医科学専攻病態制御学講座免疫・血液病制御学分野
-
佐々木 毅
東北大 院 医 分子診断学 免疫血液病制御
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
Miyazawa Keisuke
Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ
-
Kohno S
Second Dep. Of Internal Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ
-
Kohno Shigeru
佐世保市立総合病院
-
Suzuki Tatsuya
Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University
-
SUZUKI Yoshihiko
Suzuki clinic
-
Yamanaka Kiyoharu
北里大学 医学部微生物・寄生虫学
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
Sasaki Takeshi
Department of Rheumatology, Tohoku University school of Medicine
-
Tsukamoto Norifumi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
TANAKA Takashi
Department of Physics, Faculty of Science, Okayama University
-
Yamada Y
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Yamada Yasuaki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Yamada Yasuaki
富山大学 工学部
-
Kamihira Shimeru
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Yanagihara Katsunori
長崎大学 医学部第二内科
-
Yanagihara Katsunori
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
Yanagihara Katsunori
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Yanagihara Katsunori
Second Dep. Of Internal Medicine Nagasaki Univ. School Of Medicine
-
Yoshida S
Chiba University
-
Miyazaki Y
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
YAMASAKI Satoshi
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
OMATSU Mutsuko
Clinical Laboratory, National Cancer Center Hospital
-
TSUCHIYA Takahide
Department of Hematology and Oncology, Tokai University School of Medicine
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Mizuno Kyoichi
First Department Of Internal Medicine Nippon Medical School
-
Kawakami S
Santen Pharmaceutical Co. Ltd. Nara Research And Development Center:department Of Hospital Pharmacy
-
Yamada Y
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
TSUCHIDA Masahiro
Department of Pediatrics, Ibaraki Children's Hospital
-
佐々木 毅
東北大学病院血液免疫科
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
Kimura Shinya
Department Of Organic And Polymeric Materials Tokyo Institute Of Technology
-
Kawata Eri
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Kohno Shigeru
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Kohno Shigeru
長崎大学医学部歯学部附属病院 薬剤部
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
Kamatani Naoyuki
Laboratory For Statistical Analysis Center For Genomic Medicine Riken
-
MIZOGUCHI Yoshikazu
Departments of Pathology, Fujita Health University School of Medicine
-
YOKOI Takio
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
DOI Yuko
Department of Pathology, Akita University School of Medicine
-
Watanabe Naoko
Department of Internal Medicine, Tokyo Metropolitan Bokutoh Hospital
-
YAMADA Yasuaki
Department of Laboratory Medicine, Nagasaki University School of Medicine
-
KAMIHIRA Shimeru
Department of Laboratory Medicine, Nagasaki University School of Medicine
-
TSUKASAKI Kunihiro
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
MATSUO Yuzi
the Department of Laboratory Midicine
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
Ennishi Daisuke
Department Of Oncology And Hematology Cancer Institute Hospital
-
Ennishi Daisuke
癌研有明病院 血液腫瘍科
-
Akiba Takashi
Department Of Medicine Kidney Center Tokyo Women's Medical University
-
Takei Takashi
東京女子医科大学 腎臓病総合医療センター
-
Hosono Naoya
Laboratory For Genotyping Snp Research Center The Institute Of Physical And Chemical Research (riken
-
Hosono Naoya
理化学研究所遺伝子多型研究センター 薬理遺伝学研究チーム
-
Nitta Kosaku
Department Of Medicine Kidney Center Tokyo Women's Medical University
-
Nitta Kosaku
大阪大学 医学系研究科老年腎臓内科学
-
Kubo M
Department Of Environmental Medicine Graduate School Of Medical Sciences Kyushu University
-
Kubo Michiaki
理化学研究所遺伝子多型研究センター 薬理遺伝学研究チーム
-
Kubo Mitsuaki
Laboratory For Genotyping Center For Genomic Medicine Riken
-
Kubo Michiaki
九州大学 医研究院 病理病態学
-
Kamatani Yoichiro
東京大学医科学研究所ヒトゲノム解析センター ゲノムシークエンス解析
-
Kamatani Yoichiro
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science The University Of
-
KAWA Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Chil
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
NAGASAWA Masayuki
Department of Developmental Biology, Post Graduate School, Tokyo Medical and Dental University
-
UENO Hideki
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
-
OHTSU Atsushi
Gastrointestinal Oncology Division, National Cancer Center Hospital East
-
NISHIWAKI Satoshi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
YASUDA Takahiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
NIIMI Keiko
Department of Hematology, Meitetsu Hospital
-
YOKOZAWA Toshiya
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
Yamada Yasuaki
Department Of Laboratory Medicine Nagasaki University Graduate School Of Biomedical Sciences
-
YABE Hiromasa
Specialized Clinical Science, Pediatrics
-
YABE Miharu
Specialized Clinical Science, Pediatrics
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
ISHIDA Fumihiro
Department of Internal Medicine, Shinshu University School of Medicine
-
OGAWA Hiroshi
Department of Pathology, Seirei Mikatahara General Hospital
-
Tsunoda Tatsuhiko
Research Center For Animal Life Science Shiga University Of Medical Science
-
Tsunoda T
Laboratory For Medical Informatics Snp Research Center Riken (institute Of Physical And Chemical Res
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
著作論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
- Conditioning Regimen of Melphalan, Fludarabine and Total Body Irradiation in Unmanipulated HLA Haploidentical Stem Cell Transplantation Based on Feto-maternal Tolerance
- Adenocarcinomatosis of the Bone Marrow and Secondary Acute Myeloid Leukemia
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Infrequent BCL10 Mutations in B-Cell Non-Hodgkin's Lymphomas
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: A clinicopathological and immunohistological study of 21 cases
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Intravascular large B cell lymphoma : proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- IgG4-related disease : Historical overview and pathology of hematological disorders
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study